AEON Biopharma's total assets for Q1 2026 were $8.63M, an increase of 55.22% from the previous quarter. AEON total liabilities were $25.38M for the fiscal quarter, a -58.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.